Overview

Amiodarone to Prevent Post-Operative Arrhythmias

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
Rapid heart rhythms originating from the upper heart chambers (atrial tachyarrhythmias) are very common after open-heart surgery. The hypothesis of the PAPABEAR study is that a brief (13 day) peri-operative course of oral amiodarone therapy would be effective and safe for the prevention of these post-operative atrial tachyarrhythmias.
Phase:
Phase 3
Details
Lead Sponsor:
University of Calgary
Collaborators:
Heart and Stroke Foundation of Canada
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Amiodarone